UK markets open in 1 hour 3 minutes
NIKKEI 225
39,488.33 +146.79 (+0.37%) HANG SENG
17,807.19 +90.72 (+0.51%) CRUDE OIL
82.29 +0.55 (+0.67%) GOLD FUTURES
2,335.80 -0.80 (-0.03%) DOW
39,164.06 +36.26 (+0.09%) Bitcoin GBP
48,729.73 +588.13 (+1.22%)
Pharma Mar, S.A. (PHME.XC)
Cboe UK - Cboe UK Real-time price. Currency in EUR
Add to watchlist
At close: 05:18PM BST
| Previous close | 42.54 |
| Open | 42.54 |
| Bid | 41.98 x 0 |
| Ask | 33.20 x 0 |
| Day's range | 42.54 - 42.54 |
| 52-week range | 32.72 - 42.54 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 743.004M |
| Beta (5Y monthly) | -0.01 |
| PE ratio (TTM) | 709.00 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.65 (1.53%) |
| Ex-dividend date | 12 Jun 2024 |
| 1y target est | N/A |
- PR Newswire
PharmaMar presents encouraging results at ASCO for Small Cell Lung Cancer
PharmaMar (MSE: PHM), world leader in the discovery, development and commercialization of marine-derived cancer treatments, presented data from a Phase II trial evaluating PharmaMar's lurbinectedin in combination with irinotecan in patients with relapsed Small Cell Lung Cancer (SCLC) after prior platinum-based treatment at the American Society of Clinical Oncology (ASCO) meeting, which took place from 31st May to 4th June in Chicago, United States.
© 2024 Yahoo. All rights reserved.